Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company provides medical research services. It offers clinical research studies and testing such as bio-availability, equivalence, drug interaction, proof of concept, and therapeutic treatment studies.
Veeda Clinical Research Limited, is an unlisted public company incorporated on 23 April, 2004. It is classified as a public limited company and is located in , Gujarat. It's authorized share capital is INR 36.44 cr and the total paid-up capital is INR 13.16 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Nitin Jagannath Deshmukh | 00060743 | 4 years |
| Director | Rakesh Bhartia | 00877865 | 4 years |
| Nominee Director | Vivek Chhachhi | 00496620 | 7 years |
| Director | Kiran Vithaldas Marthak | 00298288 | 5 years |
| Director | Jeanne Frances Taylor Hecht | 09209900 | 4 years |
| Director | Shankarappa Nagaraja Vinaya Babu
Shareholder
|
01373832 | 4 years |
| Nominee Director | Vinayak Prabhakar Shenvi | 00694217 | 0 years |
| Nominee Director | Tanushree Akshay Agarwal | 07160692 | 2 years |
| Managing Director | Mahesh Kumar Kantilal Bhalgat | 07253670 | 2 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
GLAS TRUST CORPORATION LIMITED
No. of Loans: 1
Total Amount : 218.5 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 20.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 5.0 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 3.4 cr
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| BIONEEDS INDIA PRIVATE LIMITED | Karnataka | 2007 | ₹ 7.4 Cr |
| AMTHERA LIFE SCIENCES PRIVATE LIMITED | Karnataka | 2017 | ₹ 1.0 L |
| INGENUITY BIOSCIENCES PRIVATE LIMITED | Gujarat | 2021 | ₹ 70.0 L |
| Veeda Clinical Research Ireland Limited | Ireland | - | - |
| Health Data Specialists (Holdings) Limited | Ireland | - | - |
| Health Data Specialists Single Member S.A. | Greece | - | - |
| Health Data Specialists Ireland Limited | Ireland | - | - |
| Health Data Specialists S.R.L. | Italy | - | - |
| Health Data Specialists B.V. | Netherlands | - | - |
| Heads Research AG | Switzerland | - | - |
| Health Data Specialists USA Inc. | Usa | - | - |
| Health Data Specialists Australia Pty Ltd. | Australia | - | - |
| HeaDS research GmbH | Germany | - | - |
Read more
The incorporation date of VEEDA CLINICAL RESEARCH LIMITED is 23 April, 2004
The authorized share capital of VEEDA CLINICAL RESEARCH LIMITED is INR ₹ 36.4 Cr.
The paid-up capital of VEEDA CLINICAL RESEARCH LIMITED is INR ₹ 13.2 Cr.
The registered address of VEEDA CLINICAL RESEARCH LIMITED is SHIVALIK PLAZA-A-,2nd FLOOR OPP AHMEDABAD MANAGEMENT ASSOCIATION AMB, AWADI, AHMEDABAD, Gujarat, India, 380015 - 380015
The CIN number of VEEDA CLINICAL RESEARCH LIMITED is U73100GJ2004PLC044023.